Show
Sort by
-
- Journal Article
- A1
- open access
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023
-
- Journal Article
- A1
- open access
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols : a meta-analysis of the Ponte di Legno Toxicity working group
-
- Journal Article
- A1
- open access
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
-
- Journal Article
- A1
- open access
QUARTET : a SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer
-
- Journal Article
- A1
- open access
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
-
- Journal Article
- A1
- open access
Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma
-
Response to the letter entitled : Re : 'Prognostic value of high-risk HPV DNA and p16(INK4a) immunohistochemistry in anal cancer patients : an individual patient data meta-analysis'
-
Prognostic value of high-risk human papillomavirus DNA and p16(INK4)(a) immunohistochemistry in patients with anal cancer : an individual patient data meta-analysis
-
Skin lesions of face and scalp : classification by a market-approved convolutional neural network in comparison with 64 dermatologists
-
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma : a systematic review and meta-analysis
-
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck : the I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
-
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib : a report from the I-CML-Ped Study
-
- Journal Article
- A1
- open access
The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report
-
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy
-
The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life : a randomised controlled trial
-
Minimally invasive complete response assessment of the breast after neoadjuvant systemic therapy (MICRA trial) : interim analysis of a multicenter observational cohort study
-
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe : a report from the Innovative Therapies for Children with Cancer (ITCC) consortium
-
Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
-
Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989–2015
-
Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives : current situation, international survey and future perspectives
-
- Journal Article
- A1
- open access
Survival and prognosis with osteosarcoma : outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
-
- Journal Article
- A1
- open access
Recommendations for the organisation of care in paediatric radiation oncology across Europe : a SIOPE-ESTRO-PROS-CCI-Europe collaborative project in the framework of the JARC
-
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands
-
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
-
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
-
Menopausal hormone therapy and cancer risk : an overestimated risk?
-
Radiotherapy access in Belgium : how far are we from evidence-based utilisation?
-
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
-
Melanoma burden by melanoma stage : assessment through a disease transition model
-
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)
-
Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer
-
- Journal Article
- A1
- open access
Cost-effectiveness analysis in melanoma detection: a transition model applied to dermoscopy
-
Impact of gender on efficacy and acute toxicity of alkylating agent based chemotherapy in Ewing sarcoma : secondary analysis of the Euro-Ewing99-R1 trial
-
Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)
-
Responding to the cancer crisis: expanding global access to radiotherapy: a Lancet Oncology Commission
-
The Prostate Cancer Registry: first results from an international, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)
-
Immunohistochemical analysis of CD70 expression in 95 cases of squamous cell carcinoma of the head and neck: correlation with clinicopathological variables and identification of a novel therapeutic target
-
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
-
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
-
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy
-
Awareness of general practitioners concerning cancer patients' preferences for place of death: evidence from four European countries
-
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)
-
- Conference Paper
- C3
- open access
The AYA box: a patient centered instrument in communication with adolescents and young adults with cancer and their care giving parents
-
Adherence in elderly patients: the importance of adequate and continuous dosing
-
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
-
Suffering in silence: a qualitative study on the repercussions of having an adult child with cancer on the life of older parents
-
Temporal dynamics of the unfolded protein response and chemoresistance in hepatocellular carcinoma
-
Resistance training in patients with radically treated respiratory cancer: a prospective randomized multi-center study (REINFORCE)
-
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
-
An international expanded-access programme of everolimus : addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy